Ua hoʻolaha ʻo Brand Institute e hana pū ana me ka loea maʻi laha ʻole, ʻo Orphalan, i ka hoʻomohala ʻana i ka inoa inoa CUVRIOR™, i ʻae ʻia e ka United States Food and Drug Administration ma ʻApelila 28, 2022.
Hōʻike ʻia ʻo CUVRIOR™ no ka mālama ʻana i nā poʻe maʻi makua me ka maʻi paʻa o Wilson i hoʻopau ʻia a hoʻomanawanui i ka penicillamine. ʻO ka maʻi o Wilson he maʻi maʻi ʻaʻaʻole i ke kino mai ka wehe ʻana i ke keleawe keu aʻe, e kūkulu ʻia ke keleawe i loko o ke ake, lolo, maka, a me nā ʻano ʻē aʻe. Me ka mālama ʻole ʻana, hiki i nā pae keleawe kiʻekiʻe ke hoʻopōʻino i ke ola.
"Ke hoʻomaikaʻi aku nei ka hui holoʻokoʻa o Brand Institute a me Drug Safety Institute iā Orphalan i ka ʻae ʻana o FDA iā CUVRIOR," wahi a ka Luna Hoʻokele a me Luna Nui o Brand Institute, ʻo James L. Dettore.
E pili ana i Brand Institute a me kā mākou ʻoihana hoʻoponopono paʻa paʻa, Drug Safety Institute
ʻO Brand Institute ke alakaʻi honua i ka hoʻomohala ʻana i nā inoa e pili ana i ka lāʻau lapaʻau a me ka mālama ola kino, me kahi kōpili o ka 3,800 mau inoa inoa mālama olakino kūʻai, 1,200 USAN/INN inoa ʻole no 1,100 mau mea kūʻai. Hoʻopili ka hui ma luna o 75% o ka laikini lāʻau lapaʻau a me ka inoa ʻole i ʻae ʻia i ka honua i kēlā me kēia makahiki me nā mea hana mālama olakino. Hoʻokumu ʻia ka Drug Safety Institute o nā luna hoʻoponopono inoa mua mai nā keʻena olakino o ke aupuni honua, me ka Food and Drug Administration (FDA), European Medicines Agency (EMA), Health Canada (HC), American Medical Association (AMA), a me ka World Health Organization. (WHO). Ua kākau pū kēia mau loea hoʻoponopono i nā alakaʻi loiloi inoa ʻoiai me kā lākou mau keʻena ponoʻī, me nā kuleana he nui no ka ʻae ʻana (a hōʻole paha) i nā noi inoa inoa. Ke hana nei kēia mau limahana no kahi hui pilikino, hāʻawi kēia mau ʻoihana i nā mea kūʻai aku o Brand Institute me ke alakaʻi alakaʻi alakaʻi e pili ana i ka palekana o ka inoa lāʻau (ʻo ia hoʻi, ka pale ʻana i nā hewa o ka lāʻau lapaʻau), ka hoʻopili ʻana, a me ka lepili.
He aha e lawe ʻia mai kēia ʻatikala:
- Brand Institute is the global leader in pharmaceutical and healthcare-related name development, with a portfolio of over 3,800 marketed healthcare brand names, 1,200 USAN/INN nonproprietary names for 1,100 clients.
- Ua hoʻolaha ʻo Brand Institute e hana pū ana me ka loea maʻi laha ʻole, ʻo Orphalan, i ka hoʻomohala ʻana i ka inoa inoa CUVRIOR™, i ʻae ʻia e ka United States Food and Drug Administration ma ʻApelila 28, 2022.
- Drug Safety Institute is composed of former naming regulatory officials from global government health agencies, including Food and Drug Administration (FDA), European Medicines Agency (EMA), Health Canada (HC), American Medical Association (AMA), and the World Health Organization (WHO).
